Buscar resultados de ensayos clínicos
Choroidal Neovascularization - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial Condición: Choroidal Neovascularization Fecha: 2006-08-09 Intervenciones:
|
Completed |
Nombre del estudio: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen Condición: Choroidal Neovascularisation Fecha: 2009-12-21 Intervenciones: Drug: ranibizumab 0.5mg |
Recruiting |
Nombre del estudio: Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization Condición: Choroidal Neovascularization Fecha: 2014-10-06 Intervenciones: Drug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321) Administration by intravitreal injection |
Recruiting |
Nombre del estudio: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization Condición: Choroidal Neovascularization Fecha: 2016-08-21 Intervenciones: Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Completed |
Nombre del estudio: Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE) Condición: Choroidal Neovascularization Fecha: 2007-08-01 Intervenciones: Drug: Intravitreal injection ranibizumab Monthly intravitreal injection of 0.5mg ranibizumab in one eye |
Recruiting |
Nombre del estudio: Intravitreal Conbercept for Idiopathic Choroidal Neovascularization Condición: Idiopathic Choroidal Neovascularization Fecha: 2016-07-27 Intervenciones: Drug: conbercept 0.05ml conbercept Other Name: conbe |
Recruiting |
Nombre del estudio: Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3) Condición: Type 3 Choroidal Neovascularization Fecha: 2014-12-10 Intervenciones: Drug: Aflibercept |
Recruiting |
Nombre del estudio: TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration Condición: Choroidal Neovascularization Fecha: 2005-11-29 Intervenciones: Procedure: Photodynamic therapy versus Transpupillary thermotherapy |
Completed |
Nombre del estudio: Bevacizumab Intravitreal for Myopic Choroidal Neovascularization Condición: Myopic Choroidal Neovascularization Fecha: 2008-11-24 Intervenciones: Drug: Injection Intravitreal injection of 1.25 mg bevacizumab |
Withdrawn |
Nombre del estudio: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Condición: Choroidal Neovascularization Fecha: 2006-11-22 Intervenciones: Drug: Imatinib Mesylate /Ranibizumab |